- call +1-201-465-4211
- email sales@mrinsights.biz
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.
Scope of the Report:
This report focuses on the Endometriosis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness amongst patients and physicians. In addition, considerable research efforts towards development of novel non hormonal drugs, diagnostic and surgical techniques coupled with substantial support in terms of funding has helped to further enhance the growth of this market. Therefore, huge unmet needs for curative treatment of endometriosis will serve this market as a potential opportunity. The growth in global endometriosis market will be primarily driven by emerging Asian economies, where the disease prevalence is almost 10% of the total female population of this region.
The worldwide market for Endometriosis is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Market Segment by Applications, can be divided into
Hospital Use
Clinic Use
Other
There are 15 Chapters to deeply display the global Endometriosis market.
Chapter 1, to describe Endometriosis Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Endometriosis, with sales, revenue, and price of Endometriosis, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Endometriosis, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Endometriosis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Endometriosis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Endometriosis Introduction
1.2 Market Analysis by Type
1.2.1 Gonadotropins Releasing Hormone Agonists
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Progestin
1.2.4 Oral Contraceptive Pills
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Endometriosis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Endometriosis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer HealthCare
2.3.1 Business Overview
2.3.2 Endometriosis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer HealthCare Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Endometriosis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Addex Therapeutics
2.5.1 Business Overview
2.5.2 Endometriosis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Addex Therapeutics Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astellas Pharma
2.6.1 Business Overview
2.6.2 Endometriosis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Astellas Pharma Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Debiopharm
2.7.1 Business Overview
2.7.2 Endometriosis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Debiopharm Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 ElexoPharm
2.8.1 Business Overview
2.8.2 Endometriosis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ElexoPharm Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 EndoCeutics
2.9.1 Business Overview
2.9.2 Endometriosis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 EndoCeutics Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Euroscreen
2.10.1 Business Overview
2.10.2 Endometriosis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Euroscreen Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Forendo Pharma
2.11.1 Business Overview
2.11.2 Endometriosis Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Forendo Pharma Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Kissei Pharmaceutical
2.12.1 Business Overview
2.12.2 Endometriosis Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Kissei Pharmaceutical Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Neurocrine Biosciences
2.13.1 Business Overview
2.13.2 Endometriosis Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Neurocrine Biosciences Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Nippon Shinyaku
2.14.1 Business Overview
2.14.2 Endometriosis Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Nippon Shinyaku Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Takeda
2.15.1 Business Overview
2.15.2 Endometriosis Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Takeda Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Bayer AG
2.16.1 Business Overview
2.16.2 Endometriosis Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Bayer AG Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Neurocrine Biosciences
2.17.1 Business Overview
2.17.2 Endometriosis Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Neurocrine Biosciences Endometriosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Endometriosis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Endometriosis Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Endometriosis Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Endometriosis Manufacturer Market Share in 2017
3.3.2 Top 6 Endometriosis Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Endometriosis Market Analysis by Regions
4.1 Global Endometriosis Sales, Revenue and Market Share by Regions
4.1.1 Global Endometriosis Sales and Market Share by Regions (2013-2018)
4.1.2 Global Endometriosis Revenue and Market Share by Regions (2013-2018)
4.2 North America Endometriosis Sales and Growth Rate (2013-2018)
4.3 Europe Endometriosis Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Endometriosis Sales and Growth Rate (2013-2018)
4.5 South America Endometriosis Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Endometriosis Sales and Growth Rate (2013-2018)
5 North America Endometriosis by Countries
5.1 North America Endometriosis Sales, Revenue and Market Share by Countries
5.1.1 North America Endometriosis Sales and Market Share by Countries (2013-2018)
5.1.2 North America Endometriosis Revenue and Market Share by Countries (2013-2018)
5.2 United States Endometriosis Sales and Growth Rate (2013-2018)
5.3 Canada Endometriosis Sales and Growth Rate (2013-2018)
5.4 Mexico Endometriosis Sales and Growth Rate (2013-2018)
6 Europe Endometriosis by Countries
6.1 Europe Endometriosis Sales, Revenue and Market Share by Countries
6.1.1 Europe Endometriosis Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Endometriosis Revenue and Market Share by Countries (2013-2018)
6.2 Germany Endometriosis Sales and Growth Rate (2013-2018)
6.3 UK Endometriosis Sales and Growth Rate (2013-2018)
6.4 France Endometriosis Sales and Growth Rate (2013-2018)
6.5 Russia Endometriosis Sales and Growth Rate (2013-2018)
6.6 Italy Endometriosis Sales and Growth Rate (2013-2018)
7 Asia-Pacific Endometriosis by Countries
7.1 Asia-Pacific Endometriosis Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Endometriosis Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Endometriosis Revenue and Market Share by Countries (2013-2018)
7.2 China Endometriosis Sales and Growth Rate (2013-2018)
7.3 Japan Endometriosis Sales and Growth Rate (2013-2018)
7.4 Korea Endometriosis Sales and Growth Rate (2013-2018)
7.5 India Endometriosis Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Endometriosis Sales and Growth Rate (2013-2018)
8 South America Endometriosis by Countries
8.1 South America Endometriosis Sales, Revenue and Market Share by Countries
8.1.1 South America Endometriosis Sales and Market Share by Countries (2013-2018)
8.1.2 South America Endometriosis Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Endometriosis Sales and Growth Rate (2013-2018)
8.3 Argentina Endometriosis Sales and Growth Rate (2013-2018)
8.4 Colombia Endometriosis Sales and Growth Rate (2013-2018)
9 Middle East and Africa Endometriosis by Countries
9.1 Middle East and Africa Endometriosis Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Endometriosis Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Endometriosis Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Endometriosis Sales and Growth Rate (2013-2018)
9.3 UAE Endometriosis Sales and Growth Rate (2013-2018)
9.4 Egypt Endometriosis Sales and Growth Rate (2013-2018)
9.5 Nigeria Endometriosis Sales and Growth Rate (2013-2018)
9.6 South Africa Endometriosis Sales and Growth Rate (2013-2018)
10 Global Endometriosis Market Segment by Type
10.1 Global Endometriosis Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Endometriosis Sales and Market Share by Type (2013-2018)
10.1.2 Global Endometriosis Revenue and Market Share by Type (2013-2018)
10.2 Gonadotropins Releasing Hormone Agonists Sales Growth and Price
10.2.1 Global Gonadotropins Releasing Hormone Agonists Sales Growth (2013-2018)
10.2.2 Global Gonadotropins Releasing Hormone Agonists Price (2013-2018)
10.3 Non-Steroidal Anti-Inflammatory Drugs Sales Growth and Price
10.3.1 Global Non-Steroidal Anti-Inflammatory Drugs Sales Growth (2013-2018)
10.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Price (2013-2018)
10.4 Progestin Sales Growth and Price
10.4.1 Global Progestin Sales Growth (2013-2018)
10.4.2 Global Progestin Price (2013-2018)
10.5 Oral Contraceptive Pills Sales Growth and Price
10.5.1 Global Oral Contraceptive Pills Sales Growth (2013-2018)
10.5.2 Global Oral Contraceptive Pills Price (2013-2018)
11 Global Endometriosis Market Segment by Application
11.1 Global Endometriosis Sales Market Share by Application (2013-2018)
11.2 Hospital Use Sales Growth (2013-2018)
11.3 Clinic Use Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Endometriosis Market Forecast (2018-2023)
12.1 Global Endometriosis Sales, Revenue and Growth Rate (2018-2023)
12.2 Endometriosis Market Forecast by Regions (2018-2023)
12.2.1 North America Endometriosis Market Forecast (2018-2023)
12.2.2 Europe Endometriosis Market Forecast (2018-2023)
12.2.3 Asia-Pacific Endometriosis Market Forecast (2018-2023)
12.2.4 South America Endometriosis Market Forecast (2018-2023)
12.2.5 Middle East and Africa Endometriosis Market Forecast (2018-2023)
12.3 Endometriosis Market Forecast by Type (2018-2023)
12.3.1 Global Endometriosis Sales Forecast by Type (2018-2023)
12.3.2 Global Endometriosis Market Share Forecast by Type (2018-2023)
12.4 Endometriosis Market Forecast by Application (2018-2023)
12.4.1 Global Endometriosis Sales Forecast by Application (2018-2023)
12.4.2 Global Endometriosis Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Endometriosis Picture
Table Product Specifications of Endometriosis
Figure Global Sales Market Share of Endometriosis by Types in 2017
Table Endometrios
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
